Red Light Therapy Pads — Designed by an Australian Physiotherapist

As a physiotherapist, I've spent years researching non-invasive therapies that genuinely work at a cellular level. Photobiomodulation (PBM) — also called red and near-infrared light therapy — is one of the most evidence-backed modalities I've encountered. I have joined the global scientific community working to introduce and drive this technology into mainstream medical use — because the evidence is compelling, and Australian patients deserve access to devices that actually reflect it. But here's the problem: most devices sold online use outdated or incorrect wavelengths, which means they simply don't deliver the therapeutic depth the research supports. This article explains exactly why wavelength selection is everything, and why I designed our pads around three specific, clinically validated frequencies.

What is Photobiomodulation?

Photobiomodulation is the use of specific wavelengths of red and near-infrared light to stimulate biological processes within cells. When photons at the correct wavelength strike tissue, they are absorbed by photoreceptors — primarily cytochrome c oxidase (CCO) in the mitochondria — triggering a cascade of cellular responses including increased ATP (adenosine triphosphate) production, reduced oxidative stress, modulation of reactive oxygen species (ROS), and activation of key transcription factors that regulate inflammation and tissue repair.

In plain terms: the right light, at the right wavelength, tells your cells to produce more energy and repair faster. This is not heat therapy. It is not a placebo. It is a photochemical process with over 6,000 peer-reviewed studies supporting its mechanisms and clinical outcomes.

Why 660nm, 810nm, and 940nm — Not Just Any Red Light

The therapeutic window for PBM sits between 600nm and 1100nm, but not all wavelengths within that range are equal. The research identifies specific absorption peaks — wavelengths at which cytochrome c oxidase and other chromophores absorb photons most efficiently. Our pads use three of these validated peaks, each targeting a different tissue depth and biological mechanism.

Why Most Over-the-Counter Pads Don't Work

The red light therapy market has exploded in recent years, and with it, a flood of cheap devices that look the part but miss the science entirely. Here's what I see repeatedly when I review consumer-grade pads:

• ✕Wrong wavelengths: Many devices use 630nm or 850nm — wavelengths that sit outside the primary absorption peaks for cytochrome c oxidase. A few nanometres off sounds trivial, but it can mean the difference between therapeutic photon absorption and light that simply passes through tissue without effect.
• ✕Single wavelength only: Devices with only one wavelength (typically 660nm) address only superficial tissue. For musculoskeletal conditions — joint pain, tendinopathy, deep muscle injury — you need 810nm and 940nm to reach the target tissue. A single-wavelength pad is like treating a deep wound with a surface-only dressing.
• ✕Insufficient irradiance: Many consumer pads produce irradiance levels well below the therapeutic threshold (typically 10–100 mW/cm²). Low irradiance means insufficient photon delivery to drive the cellular response, regardless of wavelength. Our pads are calibrated to deliver clinically relevant irradiance at the tissue surface.
• ✕No clinical design input: Most pads are designed by electronics manufacturers, not clinicians. Without understanding how musculoskeletal conditions present, how tissue layers vary by body region, or what the research actually says about dosing, the product design is guesswork.

What Happens Inside the Cell

When photons at 660nm, 810nm, or 940nm are absorbed by cytochrome c oxidase, a chain of intracellular events is triggered. Nitric oxide (NO) — which had been inhibiting CCO activity — is photodissociated, restoring normal mitochondrial respiration. This leads to a rapid increase in ATP synthesis, a transient rise in reactive oxygen species (ROS) that acts as a secondary messenger, and downstream activation of transcription factors including NF-κB, AP-1, and HIF-1α.

These transcription factors regulate gene expression for anti-inflammatory cytokines, growth factors, and antioxidant enzymes — producing the clinical outcomes we observe: reduced pain, accelerated tissue repair, improved circulation, and enhanced cellular energy. The diagrams below illustrate these pathways across different wavelength ranges.

The Dosing Sweet Spot — Consistency Beats Intensity

One of the most important — and most misunderstood — aspects of PBM is the biphasic dose-response. More is not always better. Too little light produces minimal cellular response; too much can inhibit the very pathways you're trying to activate. The therapeutic window sits in the middle, and the research consistently shows that regular, correctly-dosed sessions outperform infrequent high-dose applications.

For musculoskeletal conditions, the evidence supports sessions of 10–20 minutes per treatment area, 3–5 times per week, at an irradiance of 20–100 mW/cm². Our pads are designed to operate within this window — making daily home use safe, effective, and cumulative.